Maiara Anschau Floriani

Maiara Anschau Floriani

Auto-generated profile, based on publicly available information

Maiara Anschau Floriani

Santa Casa de Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MMMilena Soriano Marcolino
Milena Soriano Marcolino
MPMagda C. Pires
Magda C. Pires
LRLucas Emanuel F. Ramos
Lucas Emanuel F. Ramos
RSRafael T. Silva
Rafael T. Silva
LOLuana M. Oliveira
Luana M. Oliveira
CPCarisi Anne Polanczyk
Carisi Anne Polanczyk
The majority of available scores to assess mortality risk of coronavirus disease 19 (COVID-19) patients in the emergency department have high risk of bias. Therefore, our aim was to develop and validate a score at hospital admission for predicting in-hospital mortality in COVID-19 patients, and to compare this score with other existing ones. Consecutive patients (≥18 years) with confirmed COVID-19 admitted to the participating hospitals were included. Logistic regression analysis was performed to develop a prediction model for in-hospital mortality, based on the 3978 patients admitted between March-July, 2020. The model was validated in the 1054 patients admitted during August-September, as well as in an external cohort of 474 Spanish patients. Median (25th-75th percentile) age of the model-derivation cohort was 60 (48-72) years, and in-hospital mortality was 20.3%. The validation cohorts had similar age distribution and in-hospital mortality. Seven significant variables were included in the risk score: age, blood urea nitrogen, number of comorbidities, C-reactive protein, SpO2/FiO2 ratio, platelet count and heart rate. The model had high discriminatory value (AUROC 0.844, 95% CI 0.829 to 0.859), which was confirmed in the Brazilian (0.859 [95% CI 0.833 to 0.885]) and Spanish (0.894 [95% CI 0.870 to 0.919]) validation cohorts, and displayed better discrimination ability than other existing scores. It is implemented in a freely available online risk calculator (https://abc2sph.com/). We designed and validated an easy-to-use rapid scoring system based on characteristics of COVID-19 patients commonly available at hospital presentation, for early stratification for in-hospital mortality risk of patients with COVID-19.

27 January 2021 in Journal of Health Economics and Outcomes Research
Verified
Journal Article
Open access
PDF file
Ana Paula Beck da Silva EtgesAna Paula Beck da Silva Etges
Ana Paula Beck da Silva Etges
RCRicardo Bertoglio Cardoso
Ricardo Bertoglio Cardoso
MMMilena Soriano Marcolino
Milena Soriano Marcolino
KRKaren Brasil Ruschel
Karen Brasil Ruschel
ACAna Paula Coutinho
Ana Paula Coutinho
LKLuciane Kopittke
Luciane Kopittke
Background: The economic impact associated with the treatment strategies of coronavirus disease-2019 (COVID-19) patients by hospitals and health-care systems in Brazil is unknown and difficult to estimate. This research describes the investments made to absorb the demand for treatment and the changes in occupation rates and billing in Brazilian hospitals. Methods: This research covers the initial findings of “COVID-19 hospital costs and the proposition of a bundled reimbursement strategy for the health-care system,” which includes 10 hospitals. The chief financial officer, the chief medical officer, and hospital executives of each participating hospital provided information regarding investments attributed to COVID-19 patient treatment. The analysis included variations in occupation rates and billing from 2019 to 2020 observed in each institution, and the investments for medical equipment, individual protection materials and building construction per patient treated. Results: The majority of hospitals registered a decrease in hospitalization rates and revenue from 2019 to 2020. For intensive care units (ICUs), the mean occupancy rate ranged from 88% to 83%, and for wards, it ranged from 85% to 73%. Monthly average revenue decreased by 10%. The mean hospital investment per COVID-19 inpatient was I$6800 (standard deviation 7664), with the purchase of ventilators as the most common investment. For this item, the mean, highest and lowest acquisition cost per ventilator were, respectively, I$31 468, I$48 881 and I$17 777. Conclusion: There was significant variability in acquisition costs and investments by institution for responding to the COVID-19 pandemic. These findings highlight the importance of continuing microeconomic studies for a comprehensive assessment of hospital costs. Only with more detailed analyses, will it be possible to define and drive sustainable strategies to manage and reimburse COVID-19 treatment in health-care systems.

2 September 2022 in BMC Medicine
Verified
Journal Article
Open access
PDF file
FFFlávio de Azevedo Figueiredo
Flávio de Azevedo Figueiredo
LRLucas Emanuel Ferreira Ramos
Lucas Emanuel Ferreira Ramos
RSRafael Tavares Silva
Rafael Tavares Silva
DPDaniela Ponce
Daniela Ponce
RCRafael Lima Rodrigues Carvalho
Rafael Lima Rodrigues Carvalho
MMMilena Soriano Marcolino
Milena Soriano Marcolino
Background: Acute kidney injury (AKI) is frequently associated with COVID-19, and the need for kidney replacement therapy (KRT) is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting the need for KRT in hospitalised COVID-19 patients, and to assess the incidence of AKI and KRT requirement. Methods: This study is part of a multicentre cohort, the Brazilian COVID-19 Registry. A total of 5212 adult COVID-19 patients were included between March/2020 and September/2020. Variable selection was performed using generalised additive models (GAM), and least absolute shrinkage and selection operator (LASSO) regression was used for score derivation. Accuracy was assessed using the area under the receiver operating characteristic curve (AUC-ROC). Results: The median age of the model-derivation cohort was 59 (IQR 47–70) years, 54.5% were men, 34.3% required ICU admission, 20.9% evolved with AKI, 9.3% required KRT, and 15.1% died during hospitalisation. The temporal validation cohort had similar age, sex, ICU admission, AKI, required KRT distribution and in-hospital mortality. The geographic validation cohort had similar age and sex; however, this cohort had higher rates of ICU admission, AKI, need for KRT and in-hospital mortality. Four predictors of the need for KRT were identified using GAM: need for mechanical ventilation, male sex, higher creatinine at hospital presentation and diabetes. The MMCD score had excellent discrimination in derivation (AUROC 0.929, 95% CI 0.918–0.939) and validation (temporal AUROC 0.927, 95% CI 0.911–0.941; geographic AUROC 0.819, 95% CI 0.792–0.845) cohorts and good overall performance (Brier score: 0.057, 0.056 and 0.122, respectively). The score is implemented in a freely available online risk calculator (https://www.mmcdscore.com/). Conclusions: The use of the MMCD score to predict the need for KRT may assist healthcare workers in identifying hospitalised COVID-19 patients who may require more intensive monitoring, and can be useful for resource allocation.

1 March 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BPBruno Barbosa Miranda de Paiva
Bruno Barbosa Miranda de Paiva
PPPolianna Delfino Pereira
Polianna Delfino Pereira
CAClaudio Moises Valiense de Andrade
Claudio Moises Valiense de Andrade
VGVirginia Mara Reis Gomes
Virginia Mara Reis Gomes
MSMaira Viana Rego Souza-Silva
Maira Viana Rego Souza-Silva
MMMilena Soriano Marcolino
Milena Soriano Marcolino
The majority of early prediction scores and methods to predict COVID-19 mortality are bound by methodological flaws and technological limitations (e.g., the use of a single prediction model). Our aim is to provide a thorough comparative study that tackles those methodological issues, considering multiple techniques to build mortality prediction models, including modern machine learning (neural) algorithms and traditional statistical techniques, as well as meta-learning (ensemble) approaches. This study used a dataset from a multicenter cohort of 10,897 adult Brazilian COVID-19 patients, admitted from March/2020 to November/2021, including patients [median age 60 (interquartile range 48–71), 46% women]. We also proposed new original population-based meta-features that have not been devised in the literature. Stacking has shown to achieve the best results reported in the literature for the death prediction task, improving over previous state-of-the-art by more than 46% in Recall for predicting death, with AUROC 0.826 and MacroF1 of 65.4%. The newly proposed meta-features were highly discriminative of death, but fell short in producing large improvements in final prediction performance, demonstrating that we are possibly on the limits of the prediction capabilities that can be achieved with the current set of ML techniques and (meta-)features. Finally, we investigated how the trained models perform on different hospitals, showing that there are indeed large differences in classifier performance between different hospitals, further making the case that errors are produced by factors that cannot be modeled with the current predictors.

19 January 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
DPDaniella Nunes Pereira
Daniella Nunes Pereira
LSLeticia Ferreira Gontijo Silveira
Leticia Ferreira Gontijo Silveira
MGMilena Maria Moreira Guimarães
Milena Maria Moreira Guimarães
CPCarisi Anne Polanczyk
Carisi Anne Polanczyk
ANAline Gabrielle Sousa Nunes
Aline Gabrielle Sousa Nunes
MMMilena Soriano Marcolino
Milena Soriano Marcolino
It is not clear whether previous thyroid diseases influence the course and outcomes of COVID-19. The study is a part of a multicentric cohort of patients with confirmed COVID-19 diagnosis from 37 hospitals. Matching for age, sex, number of comorbidities, and hospital was performed for the paired analysis. Of 7,762 patients with COVID-19, 526 had previously diagnosed hypothyroidism and 526 were matched controls. The median age was 70 years, and 68.3% were females. The prevalence of comorbidities was similar, except for coronary and chronic kidney diseases that were higher in the hypothyroidism group (p=0.015 and p=0.001). D-dimer levels were lower in patients with hypothyroid (p=0.037). In-hospital management was similar, but hospital length-of-stay (p=0.029) and mechanical ventilation requirement (p=0.006) were lower for patients with hypothyroidism. There was a trend of lower in-hospital mortality in patients with hypothyroidism (22.1% vs 27.0%; p=0.062). Patients with hypothyroidism had a lower requirement of mechanical ventilation and showed a trend of lower in-hospital mortality. Therefore, hypothyroidism does not seem to be associated with a worse prognosis.

1 June 2022 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
WSWarley Cezar da Silveira
Warley Cezar da Silveira
LRLucas Emanuel Ferreira Ramos
Lucas Emanuel Ferreira Ramos
RSRafael Tavares Silva
Rafael Tavares Silva
BPBruno Barbosa Miranda de Paiva
Bruno Barbosa Miranda de Paiva
PPPolianna Delfino Pereira
Polianna Delfino Pereira
MMMilena Soriano Marcolino
Milena Soriano Marcolino